Succesful Use of Eculizumab after Kidney Transplant for Atypical Hemolytic Uremic Syndrome (aHUS) Associated with a CFH Mutation

被引：0
|
作者：
Davin, J. -C. [1 ]
Gracchi, V. [1 ]
Bouts, A. H. [1 ]
Groothoff, J. W. [1 ]
机构：
[1] Emma Childrens Hosp, Acad Med Ctr, Pediat Nephrol Dept, Amsterdam Z O, Netherlands
来源：
PEDIATRIC NEPHROLOGY | 2010年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
471
引用
收藏
页码：1888 / 1888
页数：1
相关论文
共 50 条
  • [1] Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation
    Davin, Jean-Claude
    Gracchi, Valentina
    Bouts, Antonia
    Groothoff, Jaap
    Strain, Lisa
    Goodship, Tim
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : 708 - 711
  • [2] Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome Due to a Mutation in CFH
    Habbig, Sandra
    Bergmann, Carsten
    Weber, Lutz T.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (03) : 532 - 533
  • [3] Pregnancy-Associated Atypical Hemolytic Uremic Syndrome (aHUS), Treated with Eculizumab
    Mandala, Eudokia M.
    Gkiouzepas, Spyridon
    Kasimatis, Efstratios
    Lafaras, Christos
    Chalevas, Parthenis
    Tsioni, Konstantina
    Kyrka, Krystallia
    Oikonomidou, Dominiki
    Dinas, Konstantinos
    Loufopoulos, Aristotelis
    Efstratiadis, George
    Vasilia, Garipidou
    Garyfallos, Anastasios-Alexandros
    BLOOD, 2014, 124 (21)
  • [4] EFFICACY OF ECULIZUMAB IN ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) PATIENTS WITH OR WITHOUT PRIOR TRANSPLANT
    Legendre, Christophe
    Cohen, David
    Delmas, Yahsou
    Feldkamp, Thorsten
    Fouque, Denis
    Furman, Richard
    Gaber, Osama
    Greenbaum, Larry
    Goodship, Timothy
    Haller, Hermann
    Herthelius, Maria
    Hourmant, Maryvonne
    Licht, Christoph
    Moulin, Bruno
    Sheerin, Neil
    Trivelli, Antonella
    Bedrosian, Camille L.
    Loirat, Chantal
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 309 - 309
  • [5] ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) POST KIDNEY TRANSPLANT (KT)
    Cristina Vazquez, Maria
    Alonso, Virginia
    Soledad Costantini, Maria
    Barranco, Vanina
    Rodriguez, Sebastian
    Bertolin, Ivan
    Luis Sgrosso, Jose
    TRANSPLANT INTERNATIONAL, 2017, 30 : 445 - 445
  • [6] Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: A case report
    Sevinc M.
    Basturk T.
    Sahutoglu T.
    Sakaci T.
    Koc Y.
    Ahbap E.
    Akgol C.
    Kara E.
    Brocklebank V.
    Goodship T.H.J.
    Kavanagh D.
    Unsal A.
    Journal of Medical Case Reports, 9 (1)
  • [7] Successful Use of Eculizumab for Prevention of Atypical Hemolytic Uremic Syndrome Recurrence in a Pregnant Kidney Transplant Recipient with CFH Gene Mutation: A Case Report and Literature Review
    Zahran, Somaya
    Nodzynski, Thomas
    Matte, Catherine
    Sandal, Shaifali
    Podymow, Tiina
    Cantarovich, Marcelo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [8] Eculizumab for Preventing and Curing Post-Transplant Atypical Hemolytic Uremic Syndrome (aHUS) Recurrence
    Zuber, J.
    Le Quintrec, M.
    Krid, S.
    Gueuttin, V.
    Lahoche, A.
    Hourmant, M.
    Fremeaux-Bacchi, V.
    Niaudet, P.
    Rondeau, E.
    Legendre, C.
    Loirat, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 154 - 154
  • [9] ECULIZUMAB IMPROVES SURVIVAL IN ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) PATIENTS
    Johnson, Scott
    Khursigara, Gus
    Yen, Joseph
    Wang, Jimmy
    Silliman, Nancy
    Bedrosian, Camille
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 275 - 275
  • [10] Outcome of children with anti-CFH antibodies associated atypical hemolytic uremic syndrome (aHUS).
    Yasmeen, M.
    Vellore, K.
    Choudhary, V.
    Ganesan, K.
    Ekambaram, S.
    Senguttuvan, P.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1878 - 1878
12345